23 employees
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
2021
$30M
from 2 investors over 2 rounds
Radionetics Oncology raised $30M on October 18, 2021
Investors: 5AM Ventures and Frazier Healthcare Partners